[HTML][HTML] Efficacy of tiotropium bromide combined with different doses of fluticasone plus salmeterol DPI in the treatment of stable COPD

X Ma, J Xu, J Yang - American Journal of Translational Research, 2021 - ncbi.nlm.nih.gov
Objective: To explore the efficacy of tiotropium bromide combined with different doses of
fluticasone plus salmeterol DPI (dry powder for inhalation) in treating stable moderate to …

Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients

X Huang, X Liu, Y Luo, Y Zhou, Y Guo, C Xie - 2013 - Eur Respiratory Soc
Objective: To investigate and compare the efficacy of Tiotropium Bromide Inhalation
combined with or without low dose oral theophylline (200mg/day) in moderate to severe …

Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: a meta-analysis

Y Liu, H Shi, X Sun, D Zhang, Y Zhang, K Yang… - European Journal of …, 2014 - Elsevier
Objective This meta-analysis was performed to evaluate the efficacy and safety of adding
fluticasone propionate/salmeterol (FSC) to tiotropium (Tio) in COPD patients. Methods A …

[HTML][HTML] Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study

KS Jung, HY Park, SY Park, SK Kim, YK Kim… - Respiratory …, 2012 - Elsevier
BACKGROUND: The combination of tiotropium and fluticasone propionate/salmeterol (FSC)
is commonly used to treat chronic obstructive pulmonary disease (COPD), but no study had …

A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD

M Cazzola, F Andò, P Santus, P Ruggeri… - Pulmonary …, 2007 - Elsevier
The aim of this pilot study was to explore the relative efficacy in terms of improvement in
symptoms and lung function of combining fluticasone propionate/salmeterol combination …

Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg …

BP Yildiz, M Bayraktaroglu, H Gunen - Current Medical Research …, 2019 - Taylor & Francis
Objectives: The bronchodilator efficacy of a once-daily fixed-dose combination of
tiotropium/formoterol (18/12 µg administered via a dry-powder inhaler, Discair)[TIO …

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study

ED Bateman, M Van Dyk, A Sagriotis - Pulmonary Pharmacology & …, 2008 - Elsevier
BACKGROUND: International guidelines recommend the long-acting anticholinergic,
tiotropium, or long-acting β2-agonists as maintenance therapy in patients with moderate-to …

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone

K Kurashima, K Hara, K Yoneda, T Kanauchi… - …, 2009 - Wiley Online Library
Background and objective: The effects of tiotropium, a long‐acting anticholinergic drug, were
compared with those of the combination of salmeterol, a long‐acting β2‐agonist, and …

Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD

KF Rabe, W Timmer, A Sagkriotis, K Viel - Chest, 2008 - Elsevier
Background A 6-week, multicenter, randomized, double-blind, parallel-group study was
conducted in patients with COPD to compare lung function improvements of tiotropium, 18 …

[PDF][PDF] A comparative study on safety profile and efficacy of salmeterol and tiotropium in COPD Patients

K Jagadeesh, R Vandana, BA Varun, G Vinod… - 2024 - wjarr.com
Abstract Aim and Objectives: The aim of the study is assess the safety profile and efficacy of
salmeterol and Tiotropium in patients with COPD. The objective is to compare to evaluate …